Maraldi N M, Zini N, Sabatelli P, Valmori A, Scotlandi K, Serra M, Baldini N
Institute of Normal and Pathologic Cytomorphology.
J Submicrosc Cytol Pathol. 1996 Jan;28(1):93-100.
The multiple drug type of resistance to anticancer agents (MDR) is mediated by an over-expression of the MDR1 gene product, the P-glycoprotein. This is largely present at the cell surface of MDR cells, mediating the active efflux of cytotoxic molecules, but may be found also intracellularly. In this paper, using Saos-2 human osteosarcoma cells as a model, we provide further evidence of increased presence of P-glycoprotein at the plasma membrane and in the nucleus of MDR cells, where it is closely bound to the nuclear matrix. The structural changes observed in Saos-2 MDR cells, including an increase of the cell surface by the formation of blebs, and a peculiar clustering of chromatin, which are similar to those observed in other MDR cell lines, are likely to be associated with the observed overexpression of the P-glycoprotein at the cell membrane and nuclear level. These findings suggest the existence of more complex, still undetermined, mechanisms underlying the MDR phenomenon.
抗癌药物的多重耐药性(MDR)是由MDR1基因产物P-糖蛋白的过度表达介导的。它主要存在于MDR细胞的细胞表面,介导细胞毒性分子的主动外排,但在细胞内也可能存在。在本文中,我们以Saos-2人骨肉瘤细胞为模型,进一步证明了P-糖蛋白在MDR细胞的质膜和细胞核中含量增加,且与核基质紧密结合。在Saos-2 MDR细胞中观察到的结构变化,包括通过形成泡状结构使细胞表面积增加,以及染色质的特殊聚集,这些与在其他MDR细胞系中观察到的变化相似,可能与在细胞膜和细胞核水平观察到的P-糖蛋白过度表达有关。这些发现表明,MDR现象背后存在更复杂、尚未确定的机制。